Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary

Joshua A. Copel, Lawrence D. Platt, John C. Hobbins, Yalda Afshar, Olga Grechukhina, Divya Mallampati, Bryann Bromley, Aaron B. Caughey, William Grobman, Christina S. Han, Kypros Nicolaides, Christian Pettker, George Saade, Baha Sibai, Hygrav Simhan, Jiri Sonek, Erika Werner, Nancy Chescheir

Research output: Contribution to journalArticle

Abstract

Preeclampsia is responsible for significant maternal and neonatal morbidity and is associated with a substantial economic burden. Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis. In May 2018, the Gottesfeld-Hohler Memorial Foundation organized a working group meeting with the goal of identifying the optimal preeclampsia risk-assessment strategy and consequent intervention in the United States. The meeting brought together experts from the leading professional societies. We discussed available literature and trends in preeclampsia risk assessment, current professional guidelines for identifying women at risk for preeclampsia, prophylactic use of aspirin in the United States and Europe, cost-effectiveness data, and feasibility of implementation of different assessment tools and preventive strategies in the United States. We identified specific knowledge gaps and future research directions in preeclampsia risk assessment and prevention that need to be addressed before practice change.

Original languageEnglish (US)
Pages (from-to)36-45
Number of pages10
JournalObstetrics and gynecology
Volume135
Issue number1
DOIs
StatePublished - Jan 1 2020

Fingerprint

Pre-Eclampsia
Aspirin
Group Processes
Health Services Needs and Demand
Cost-Benefit Analysis
Consensus
Economics
Mothers
Guidelines
Morbidity

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Copel, J. A., Platt, L. D., Hobbins, J. C., Afshar, Y., Grechukhina, O., Mallampati, D., ... Chescheir, N. (2020). Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary. Obstetrics and gynecology, 135(1), 36-45. https://doi.org/10.1097/AOG.0000000000003582

Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States : Think Tank Summary. / Copel, Joshua A.; Platt, Lawrence D.; Hobbins, John C.; Afshar, Yalda; Grechukhina, Olga; Mallampati, Divya; Bromley, Bryann; Caughey, Aaron B.; Grobman, William; Han, Christina S.; Nicolaides, Kypros; Pettker, Christian; Saade, George; Sibai, Baha; Simhan, Hygrav; Sonek, Jiri; Werner, Erika; Chescheir, Nancy.

In: Obstetrics and gynecology, Vol. 135, No. 1, 01.01.2020, p. 36-45.

Research output: Contribution to journalArticle

Copel, JA, Platt, LD, Hobbins, JC, Afshar, Y, Grechukhina, O, Mallampati, D, Bromley, B, Caughey, AB, Grobman, W, Han, CS, Nicolaides, K, Pettker, C, Saade, G, Sibai, B, Simhan, H, Sonek, J, Werner, E & Chescheir, N 2020, 'Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary', Obstetrics and gynecology, vol. 135, no. 1, pp. 36-45. https://doi.org/10.1097/AOG.0000000000003582
Copel, Joshua A. ; Platt, Lawrence D. ; Hobbins, John C. ; Afshar, Yalda ; Grechukhina, Olga ; Mallampati, Divya ; Bromley, Bryann ; Caughey, Aaron B. ; Grobman, William ; Han, Christina S. ; Nicolaides, Kypros ; Pettker, Christian ; Saade, George ; Sibai, Baha ; Simhan, Hygrav ; Sonek, Jiri ; Werner, Erika ; Chescheir, Nancy. / Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States : Think Tank Summary. In: Obstetrics and gynecology. 2020 ; Vol. 135, No. 1. pp. 36-45.
@article{d9aefb1613f64aec89464fc9bde5a5e1,
title = "Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary",
abstract = "Preeclampsia is responsible for significant maternal and neonatal morbidity and is associated with a substantial economic burden. Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis. In May 2018, the Gottesfeld-Hohler Memorial Foundation organized a working group meeting with the goal of identifying the optimal preeclampsia risk-assessment strategy and consequent intervention in the United States. The meeting brought together experts from the leading professional societies. We discussed available literature and trends in preeclampsia risk assessment, current professional guidelines for identifying women at risk for preeclampsia, prophylactic use of aspirin in the United States and Europe, cost-effectiveness data, and feasibility of implementation of different assessment tools and preventive strategies in the United States. We identified specific knowledge gaps and future research directions in preeclampsia risk assessment and prevention that need to be addressed before practice change.",
author = "Copel, {Joshua A.} and Platt, {Lawrence D.} and Hobbins, {John C.} and Yalda Afshar and Olga Grechukhina and Divya Mallampati and Bryann Bromley and Caughey, {Aaron B.} and William Grobman and Han, {Christina S.} and Kypros Nicolaides and Christian Pettker and George Saade and Baha Sibai and Hygrav Simhan and Jiri Sonek and Erika Werner and Nancy Chescheir",
year = "2020",
month = "1",
day = "1",
doi = "10.1097/AOG.0000000000003582",
language = "English (US)",
volume = "135",
pages = "36--45",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States

T2 - Think Tank Summary

AU - Copel, Joshua A.

AU - Platt, Lawrence D.

AU - Hobbins, John C.

AU - Afshar, Yalda

AU - Grechukhina, Olga

AU - Mallampati, Divya

AU - Bromley, Bryann

AU - Caughey, Aaron B.

AU - Grobman, William

AU - Han, Christina S.

AU - Nicolaides, Kypros

AU - Pettker, Christian

AU - Saade, George

AU - Sibai, Baha

AU - Simhan, Hygrav

AU - Sonek, Jiri

AU - Werner, Erika

AU - Chescheir, Nancy

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Preeclampsia is responsible for significant maternal and neonatal morbidity and is associated with a substantial economic burden. Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis. In May 2018, the Gottesfeld-Hohler Memorial Foundation organized a working group meeting with the goal of identifying the optimal preeclampsia risk-assessment strategy and consequent intervention in the United States. The meeting brought together experts from the leading professional societies. We discussed available literature and trends in preeclampsia risk assessment, current professional guidelines for identifying women at risk for preeclampsia, prophylactic use of aspirin in the United States and Europe, cost-effectiveness data, and feasibility of implementation of different assessment tools and preventive strategies in the United States. We identified specific knowledge gaps and future research directions in preeclampsia risk assessment and prevention that need to be addressed before practice change.

AB - Preeclampsia is responsible for significant maternal and neonatal morbidity and is associated with a substantial economic burden. Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis. In May 2018, the Gottesfeld-Hohler Memorial Foundation organized a working group meeting with the goal of identifying the optimal preeclampsia risk-assessment strategy and consequent intervention in the United States. The meeting brought together experts from the leading professional societies. We discussed available literature and trends in preeclampsia risk assessment, current professional guidelines for identifying women at risk for preeclampsia, prophylactic use of aspirin in the United States and Europe, cost-effectiveness data, and feasibility of implementation of different assessment tools and preventive strategies in the United States. We identified specific knowledge gaps and future research directions in preeclampsia risk assessment and prevention that need to be addressed before practice change.

UR - http://www.scopus.com/inward/record.url?scp=85077106723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077106723&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000003582

DO - 10.1097/AOG.0000000000003582

M3 - Article

C2 - 31809427

AN - SCOPUS:85077106723

VL - 135

SP - 36

EP - 45

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -